Schistosomiasis as a predisposing factor to veno-occlusive disease of the liver following allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 17, Issue 3, 1996, Pages 401-403

  Mahmoud, H K ^a,b  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL CANCER INSTITUTE   (Egypt)

Author keywords

Schistosomiasis; VOD

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BETA THALASSEMIA; CHILD; CHRONIC MYELOID LEUKEMIA; ECHOGRAPHY; FEMALE; HUMAN; INCIDENCE; LIVER FIBROSIS; LIVER FUNCTION; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PORTAL HYPERTENSION; PRIORITY JOURNAL; RISK; SCHISTOSOMIASIS;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CAUSALITY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; LIVER; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SCHISTOSOMIASIS; TRANSPLANTATION, HOMOLOGOUS; VENOUS INSUFFICIENCY;

EID: 0029981276     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. McDonald GB, Shulman HM, Wolford JL, Spencer GD. Liver disease after human bone marrow transplantation. Semin Liver Dis 1987; 7: 210-229.
2. Shulman HM, McDonald GB, Mathews D et al. An analysis of hepatic veno-occlusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 1990; 79: 1178-1191.
3. Shulman HM, Hinterberger W. Hepatic veno-occlusive disease-liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197-214.
4. McDonald GB, Hinds M, Fisher L. Schoch HG. Liver toxicity following cytoreductive therapy for marrow transplantation: risk factors, incidence and outcome. Hepatotogy 1991; 14: 162a (abstr. 459).
5. El-Rooby A. Management of hepatic schistosomiasis. Semin Liver Dis 1985; 5: 263-276.
6. Mahmoud AA. Current concepts: schistosomiasis. New Engl J Med 1977; 297: 1329-1331.
7. Warren KS. The relevance of schistosomiasis. New Engl J Med 1980; 303: 203-206.
8. Nash TE, Cheever AW, Ottesen EA, Cook JA. Schistosome infections in humans. Ann Intern Med 1982; 97: 740-754.
9. Boros DL. Immunology of Schistosomiasis mansoni infection. Clin Microbial Rev 1989; 2: 250-269.
10. El Lammie O, Salama Z. Ultrasonography of the liver and biliary tree. In: Sherif SM, Baddar MR, Zakaria MS (eds). Update: Hepatology and Gastroenterology. Druck und Verlagsgesellschaft: Hamburg, 1992, pp 33-47.
11. Shulman HM, Hinds M, Schoch HG, McDonald GB. Liver toxicity after marrow transplantation: correlation between coded autopsy histology and clinical features. Lab Invest 1992; 66: 586 (99a).
12. McDonald GB, Shanna P, Mathews DE et al. Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors. Hepatology 1984; 4: 116-122.
13. Martin PJ. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors. Bone Marrow Transplant 1991; 8: 217-223.
14. Jones RJ, Lee KSK, Beschomer W et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778-783.
15. McDonald CG, Shorma P, Mathews DE et al. The clinical course of 53 patients with veno-occlusive disease of the liver after marrow transplantation. Transplantation 1985; 39: 603-608.
16. Capron A, Dessaint JP. Immunologic aspects of schistosomiasis. Annu Rev Med 1992; 43: 209-218.
17. Baglin TP. Veno-occlusive disease of the liver complicating bone marrow transplantation. Bone Marrow Transplant 1994; 13: 1-4.
18. Dulley F, Konfer E, Appelbaum F. Veno-occlusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. Transplantation 1987; 43: 870-873.
19. Deeg H, Shulman H, Schmidt E et al. Marrow rejection and veno-occlusive disease of the liver in patients with aplastic anaemia conditioned with cyclophosphamide and cyclosporin. Transplantation 1986; 42: 497-501.
20. 1 for prevention of liver veno-occlusive disease in leukaemia patients treated by allogeneic bone marrow transplantation. Br J Haematol 1990; 74: 277-281.